tradingkey.logo
tradingkey.logo
Search

CSL Vifor And Travere Therapeutics Announce Standard EU Approval For Filspari® In Iga Nephropathy

ReutersApr 29, 2025 6:04 AM
facebooktwitterlinkedin

- CSL Ltd CSL.AX:

  • CSL VIFOR AND TRAVERE THERAPEUTICS ANNOUNCE STANDARD EU APPROVAL FOR FILSPARI® IN IGA NEPHROPATHY

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI